Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease
J. Van Boven, H. Benhaddi, N. Roche, L. Bjermer, M. Miravitlles, J. Voorham, D. Price
Research output: Contribution to journal › Meeting Abstract › Academic
Fingerprint
Dive into the research topics of 'Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease'. Together they form a unique fingerprint.